Halozyme Therapeutics, Inc. (HALO)

Last Three Months

29-Dec-23 -- 28-Mar-24

Time Period:
  • Three Months
  •  | 
  • Year

0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
0
(2)
0
(1)
32
0
4
+1
0
+2
0
+3

Two Year Chart

29-Mar-22 -- 28-Mar-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
20-Feb-24 6:49 PM
View: 
16-Feb-24
Payment of Exercise
($735.07K)
Torley Helen
President and CEO
Director
Insider Trading Sentiment for Torley Helen at Halozyme Therapeutics, Inc. (HALO):Halozyme Therapeutics, Inc. - HALO9%
623.67K to 676.74K
0
0
---- Show TxnsShow Insider Trades
26-Mar-24 7:38 PM
View: 
26-Mar-24
Option Exercise
$130.16K
Labarre Michael J.
SVP, Chief Technical Officer
Insider Trading Sentiment for Labarre Michael J. at Halozyme Therapeutics, Inc. (HALO):Halozyme Therapeutics, Inc. - HALO11%
151.91K to 168.18K
0
0
---- Show TxnsShow Insider Trades
20-Feb-24 6:55 PM
View: 
16-Feb-24
Payment of Exercise
($93.03K)
Snyder Mark Howard
SVP, General Counsel
Insider Trading Sentiment for Snyder Mark Howard at Halozyme Therapeutics, Inc. (HALO):Halozyme Therapeutics, Inc. - HALO143%
4.81K to 11.68K
0
0
---- Show TxnsShow Insider Trades
20-Feb-24 6:53 PM
View: 
16-Feb-24
Payment of Exercise
($202.20K)
Labrosse Nicole
SVP, Chief Financial Officer
Insider Trading Sentiment for Labrosse Nicole at Halozyme Therapeutics, Inc. (HALO):Halozyme Therapeutics, Inc. - HALO71%
9.07K to 15.48K
0
0
---- Show TxnsShow Insider Trades